期刊文献+

糖原累积病Ⅱ型1例的临床特点及基因突变分析 被引量:1

Clinical Characteristics and Gene Mutation Analysis of a Child with Glycogen Storage Disease Type Ⅱ
下载PDF
导出
摘要 目的:分析1例儿童糖原累积病Ⅱ型的临床特点及基因突变位点。方法:对重庆医科大学附属儿童医院收治的1例通过基因测序明确诊断的糖原累积病Ⅱ型患儿的临床资料如临床特点、实验室检查、基因突变进行分析。结果:本例患儿起病隐匿,以乏力、肝功能异常为主要表现,临床表现不十分典型。通过基因测序发现2个基因突变位点,包括c.2238G>C(p.W746C)及c.2608C>T(p.R870X),2个突变位点既往均被证实与糖原累积病Ⅱ型相关。本例患儿未给予酶替代治疗,治疗结局需要继续随访。结论:糖原累积病Ⅱ型是由GAA基因突变引起的GAA活性降低所致,GAA基因检测是可行、有效的诊断方法。 Objective:To analysis the clinical features and gene mutation of a child with glycogen storage disease type Ⅱ.Methods:We selected the clinical data such as clinical features,laboratory examination and gene mutation,which were diagnosed glycogen storage disease type Ⅱ with gene sequencing in the Children's Hospital of Chongqing Medical University.Results:This child with atypia clinical manifestation and the clinical features were increasing gradually which were characterized by fatigue and abnormal liver function.Gene detection revealed 2 compound heterozygous mutations in the child,included c.2238 G〉C(p.W746C) and c.2608 C〉T(p.R870X).The two gene mutations had been proved pathogenic with glycogen storage disease type Ⅱ.This child with no enzyme replacement therapy and the follow-up of treatment results was necessary.Conclusion:Glycogen storage disease type Ⅱ is caused by deficiency of GAA activity resulting from mutation of GAA gene.The detection of GAA gene sequencing is effective and feasible method for diagnosis of glycogen storage disease type Ⅱ.
作者 甘川 许红梅
出处 《儿科药学杂志》 CAS 2017年第9期25-27,共3页 Journal of Pediatric Pharmacy
关键词 糖原累积病Ⅱ型 临床特点 基因突变 glycogen storage disease type Ⅱ clinical features gene mutation
  • 相关文献

参考文献2

二级参考文献23

  • 1傅立军,窦薇,周爱卿,黄美蓉,杨健萍,李奋.糖原累积病Ⅱ型的临床分析和基因学检测[J].临床儿科杂志,2006,24(12):962-965. 被引量:11
  • 2Hasan zen.Glycogen storage diseases: New perspectives[J].World Journal of Gastroenterology,2007,13(18):2541-2553. 被引量:29
  • 3仇佳晶,魏珉,张为民,施惠平.幼年起病的2例晚发型糖原贮积症Ⅱ型/Pompe病临床和基因分析[J].中华儿科杂志,2007,45(10):760-764. 被引量:11
  • 4Kroos M, Pomponio RJ, van Vliet L, et al. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Hum Murat, 2008, 29 :E13-E26.
  • 5Vedsted P, Mainz J, Olesen F. [ The significance of a reminder and physician's motivation for the response rate of a questionnaire survey in general practice]. Ugeskr Laeger, 2001, 163:5529- 5532.
  • 6Tsujino S, Huie M, Kanazawa N, et al. Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord, 2000, 10:599-603.
  • 7Fernandez-Hojas R, Huie ML, Navarro C, et al. Identification of six novel mutations in the acid alpha-glucosidase gene in threeSpanish patients with infantile onset glycogen storage disease type ( Pompe disease). Neuromuscul Disord, 2002, 12 : 159-166.
  • 8Malicdan MC, Nishino I. Autophagy in lysosomal myopathies. Brain Pathol, 2012, 22:82-88.
  • 9Winkel LP, Van den Hout JM, Kamphoven JH, et al. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Ann Neurol, 2004, 55:495-502.
  • 10Mellies U, Stehling F, Dohna-Schwake C, et al. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology, 2005, 64 : 1465-1467.

共引文献8

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部